Elsevier

Biochemical Pharmacology

Volume 39, Issue 12, 15 June 1990, Pages 1897-1904
Biochemical Pharmacology

Activities of caffeine, theophylline, and enprofylline analogs as tracheal relaxants

https://doi.org/10.1016/0006-2952(90)90607-MGet rights and content

Abstract

A variety of xanthines cause tracheal relaxation, an activity predictive of antiasthmatic potential. Structural analogs of caffeine, theophylline, and enprofylline were examined for their abilities to relax carbamylcholine-stimulated guinea pig trachea in vitro. All caffeine analogs tested were more potent than caffeine (ec50 = 551 ± 81μM) except the 8-p-sulfophenyl analog. 1,3,7-Tripropylxanthine and 1,3,7-tripropargylxanthine were among the more potent analogs with ec50 values of 12 ± 1.3 and 65 ± 11 μM respectively. Increasing the polarity at the 1- or 3-position by substituting a propargyl group for an n-propyl group decreased relaxant activity, an effect not observed at the 7-position. The 8-cyclohexyl-, 8-cyclopentyl- and 8-phenyl-derivatives of caffeine were relatively potent (ec50 = approximately 75 μM). The theophylline analog 1,3-di-n-propylxanthine was approximately two times more active than theophylline (ec50 = 162 ± 17 μM). 3-Isobutyl-1-methylxanthine (ec50 = 7.1 ± 1.8 μM) and 1-isoamyl-3-isobutylxanthine (ec50 = 37 ± 4.2 μM) were among the most potent tracheal relaxants. The 8-substituted theophylline analogs were weak or inactive relaxants except for 8-cyclopentyl- and 8-cyclohexyltheophylline, which were more potent or as potent as theophylline. In contrast to enprofylline (ec50 = 56 ± 9 μM), 8-substituted enprofylline analogs were weak or inactive as relaxants with the exception of the 8-cyclohexyl analog. The potency of xanthines as tracheal relaxants was unrelated to potency as adenosine receptor antagonists and may reflect activity as phosphodiesterase inhibitors.

References (35)

  • G Ghai et al.

    Evidence for A1 and A2 adenosine receptors in guinea pig trachea

    Life Sci

    (1987)
  • D Ukena et al.

    Analogs of caffeine: Antagonists with selectivity for A2 adenosine receptors

    Life Sci

    (1986)
  • JB Polson et al.

    Correlation between inhibition of a cyclic GMP phosphodiesterase and relaxation of canine tracheal smooth muscle

    Biochem Pharmacol

    (1985)
  • P Schoeffter et al.

    Role of cyclic AMP- and cyclic GMP-phospho-diesterase in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta: A study with selective inhibitors

    Biochem Pharmacol

    (1987)
  • PH Wu et al.

    Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: Evaluation of structure-activity relationships

    Life Sci

    (1982)
  • CGA Persson et al.

    Enprofylline, a principally new antiasthmatic xanthine

    Acta Pharmacol Toxicol

    (1981)
  • Lunell E et al.

    Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease

    Eur J Clin Pharmacol

    (1982)
  • Cited by (24)

    • Dose-effect and concentration-effect analysis

      2021, Atkinson's Principles of Clinical Pharmacology
    • Dose–Effect and Concentration–Effect Analysis

      2012, Principles of Clinical Pharmacology, Third Edition
    • Dose-effect and Concentration-Effect Analysis

      2007, Principles of Clinical Pharmacology
    • Dose-Effect and Concentration-Effect Analysis

      2006, Principles of Clinical Pharmacology
    View all citing articles on Scopus
    View full text